Algorae Pharmaceuticals Limited
LVCLF
Get informed when a big investor buys or sells
+ FollowMarket Cap$19.36M
Close$
Share Statistics
| Market cap | $19.36 Million |
|---|---|
| Enterprise Value | $16.18 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | -0.03 |
| Outstanding Shares | 1,817,823,164 |
Return
| Return on Equity | -84.89% |
|---|---|
| Return on Assets | -81.51% |
| Return on Invested Capital | -101.57% |
Valuation & Multiples
| P/E Ratio | -4.44 |
|---|---|
| PEG | -0.37 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.74 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Algorae Pharmaceuticals Limited
48 employees
CEO: David Richard Hainsworth Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the fir...